| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | EHT 1864 | GDSC1000 | pan-cancer | AAC | -0.0061 | 0.9 |
| mRNA | NSC632839 | CTRPv2 | pan-cancer | AAC | 0.0056 | 0.9 |
| mRNA | paclitaxel | UHNBreast | pan-cancer | AAC | -0.051 | 0.9 |
| mRNA | nintedanib | CTRPv2 | pan-cancer | AAC | 0.0062 | 0.9 |
| mRNA | PHA-665752 | GDSC1000 | pan-cancer | AAC | -0.0092 | 0.9 |
| mRNA | BRD-K07442505 | CTRPv2 | pan-cancer | AAC | -0.0058 | 0.9 |
| mRNA | thapsigargin | gCSI | pan-cancer | AAC | -0.0082 | 0.9 |
| mRNA | linifanib | GDSC1000 | pan-cancer | AAC | 0.0056 | 0.9 |
| mRNA | BRD-K55473186 | CTRPv2 | pan-cancer | AAC | -0.0071 | 0.9 |
| mRNA | Methotrexate | CTRPv2 | pan-cancer | AAC | 0.0055 | 0.9 |